Deeper Knowledge, Faster

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Argus Health
Farmers Insurance
Fish and Richardson

Generated: November 22, 2017

DrugPatentWatch Database Preview

Details for Patent: 3,954,872

« Back to Dashboard

Summary for Patent: 3,954,872

Title: 1-(2',6'-Dimethyl-phenoxy)-2-amino-alkanes and salts thereof
Abstract:Compounds of the formula ##EQU1## wherein R is hydrogen or alkyl of 1 to 3 carbon atoms, and R.sub.1 is hydrogen or methyl, And non-toxic, pharmacologically acceptable acid addition salts thereof; the compounds as well as their salts are useful as anticonvulsives and antiarrhythmics in warmblooded animals.
Inventor(s): Koppe; Herbert (Ingelheim am Rhein, DT), Zeile; Karl (Ingelheim am Rhein, DT), Kummer; Werner (Ingelheim am Rhein, DT), Stahle; Helmut (Ingelheim am Rhein, DT), Danneberg; Peter (Ingelheim am Rhein, DT)
Assignee: Boehringer Ingelheim GmbH (Ingelheim am Rhein, DT)
Application Number:05/511,063
Patent Claim Types:
see list of patent claims

No matches for this query

Foreign Priority and PCT Information for Patent: 3,954,872

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
88950Sep 16, 1966
94024Aug 17, 1967

International Patent Family for Patent: 3,954,872

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria288353► Subscribe
Austria289075► Subscribe
Austria291225► Subscribe
Switzerland509250► Subscribe
Switzerland509251► Subscribe
Switzerland509252► Subscribe
Switzerland516512► Subscribe
Switzerland518259► Subscribe
Germany1543369► Subscribe
Germany1643240► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus